Structured Combined Exercise Program in Postmenopausal Women: Effects on Heart Rate Variability and Menopausal Symptoms
The Effect of a Structured Combined Exercise Program on Heart Rate Variability and Menopausal Symptoms in Postmenopausal Women: A Randomized Controlled Trial
The goal of this clinical trial is to learn whether a structured combined exercise program can improve heart health, menopausal symptoms, sleep quality, and quality of life in postmenopausal women aged 45 to 65 years.
The main questions it aims to answer are:
Does the exercise program improve heart rate variability, which shows how well the heart is controlled by the nervous system? Does the exercise program lower menopausal symptoms? Does the exercise program improve sleep quality and quality of life?
Researchers will compare women who join the exercise program with women who continue their usual daily activities.
Participants in the exercise group will take part in a supervised exercise program for 12 weeks. They will exercise 2 days each week. Each session will last 45 minutes and will include warm-up, balance, strengthening, coordination, flexibility, and cool-down exercises.
Participants in the control group will continue their usual daily activities during the study.
研究概览
详细说明
Menopause is associated with hormonal changes that may negatively affect cardiovascular, neurological, and psychological health. Reduced estrogen levels during the postmenopausal period have been linked to autonomic nervous system dysfunction, increased cardiovascular risk, vasomotor symptoms, sleep disturbances, anxiety, depressive symptoms, and reduced quality of life. Heart rate variability (HRV) is a non-invasive marker of cardiac autonomic nervous system function and reflects the balance between sympathetic and parasympathetic activity. Lower HRV values have been associated with stress, poor sleep quality, and psychological symptoms in postmenopausal women.
Exercise is considered one of the most effective non-pharmacological interventions for improving menopausal symptoms and cardiovascular health. Previous studies suggest that regular exercise may improve autonomic nervous system regulation and HRV. However, evidence regarding the effects of structured combined exercise programs on HRV and menopausal symptoms in postmenopausal women remains limited and inconsistent. In addition, few randomized controlled studies have examined the relationship between changes in autonomic nervous system function and menopausal symptoms.
This randomized controlled trial aims to investigate the effects of a structured combined exercise program on cardiac autonomic nervous system function assessed by HRV in postmenopausal women. Secondary aims are to evaluate the effects of the exercise program on menopausal symptoms, sleep quality, and quality of life, and to examine the relationship between changes in HRV and symptom-related outcomes.
The intervention will consist of a 12-week supervised structured combined exercise program performed twice weekly. Each session will include warm-up, balance, strengthening, coordination, flexibility, and cool-down exercises. Exercises will be progressively adjusted according to participants' functional capacity and performed under physiotherapist supervision.
Statistical analyses will be conducted using IBM SPSS Statistics version 25.0. Data distribution will be assessed using the Kolmogorov-Smirnov and Shapiro-Wilk tests. Appropriate parametric and non-parametric statistical tests will be used for within-group and between-group comparisons. Statistical significance will be accepted at p < 0.05.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名：Burcu Akkurt, PhD
- 电话号码：+90 553 604 6713
- 邮箱：burcu.akkurt@fbu.edu.tr
学习地点
-
-
Atasehir
-
Istanbul、Atasehir、土耳其（türkiye）
- 招聘中
- Fenerbahce University
-
接触：
- Burcu Akkurt, PhD
- 电话号码：+90 553 604 6713
- 邮箱：burcu.akkurt@fbu.edu.tr
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Women in the postmenopausal period
- Aged between 45 and 65 years
- Able to communicate and cooperate with the researchers
- Not participating in another structured exercise program
- Willing to participate voluntarily in the study
Exclusion Criteria:
- Presence of severe cardiovascular, neurological, orthopedic, or psychiatric disease
- Hormone replacement therapy use during the study period
- Cognitive impairment affecting participation
- Uncontrolled hypertension or other unstable medical conditions
- Regular participation in structured exercise training within the last 6 months
- Smoking or alcohol use that may affect heart rate variability measurements
学习计划
研究是如何设计的？
设计细节
- 主要用途：治疗
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：无（打开标签）
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：Exercise Group
Participants will receive a 12-week structured combined exercise program performed twice weekly under physiotherapist supervision.
|
The intervention consists of a supervised 12-week structured combined exercise program performed twice weekly.
Each 45-minute session includes warm-up, balance, strengthening, coordination, flexibility, and cool-down exercises.
|
|
无干预：Control Group
Participants in the control group will continue their usual daily activities and will not receive any structured exercise intervention during the study period.
At the end of the study, participants in the control group will be informed about the exercise program, and volunteers will be offered the opportunity to participate in the program in accordance with ethical considerations.
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Heart Rate Variability
大体时间：Baseline, immediately after the 12-week intervention, and 8 weeks after the intervention
|
Cardiac autonomic nervous system function will be assessed using heart rate variability parameters including standard deviation of normal-to-normal intervals (SDNN), root mean square of successive differences (RMSSD), low-frequency power (LF), high-frequency power (HF), and low-frequency/high-frequency ratio (LF/HF ratio).
|
Baseline, immediately after the 12-week intervention, and 8 weeks after the intervention
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Menopause Rating Scale
大体时间：Baseline, immediately after the 12-week intervention, and 8 weeks after the intervention
|
Menopausal symptoms will be assessed using the Menopause Rating Scale (MRS), an 11-item questionnaire evaluating somatic, psychological, and urogenital symptoms.
Each item is scored from 0 (no symptoms) to 4 (very severe symptoms).
Total scores range from 0 to 44, with higher scores indicating more severe menopausal symptoms.
|
Baseline, immediately after the 12-week intervention, and 8 weeks after the intervention
|
|
Sleep Quality
大体时间：Baseline, immediately after the 12-week intervention, and 8 weeks after the intervention
|
Sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI), a self-reported questionnaire with scores ranging from 0 to 21.
Higher scores indicate poorer sleep quality.
|
Baseline, immediately after the 12-week intervention, and 8 weeks after the intervention
|
|
Menopause-Specific Quality of Life
大体时间：Baseline, immediately after the 12-week intervention, and 8 weeks after the intervention
|
Menopause-specific quality of life will be assessed using the Menopause-Specific Quality of Life Questionnaire (MENQOL).
The questionnaire assesses vasomotor, psychosocial, physical, and sexual domains.
Item and domain scores range from 1 to 8, with higher scores indicating poorer menopause-specific quality of life.
|
Baseline, immediately after the 12-week intervention, and 8 weeks after the intervention
|
|
Depressive Symptoms
大体时间：Baseline, immediately after the 12-week intervention, and 8 weeks after the intervention
|
Depressive symptoms will be assessed using the Geriatric Depression Scale-Short Form (GDS-SF), a 15-item questionnaire with scores ranging from 0 to 15.
Higher scores indicate more severe depressive symptoms.
|
Baseline, immediately after the 12-week intervention, and 8 weeks after the intervention
|
|
Hot Flash Frequency and Severity
大体时间：Daily throughout the 12-week intervention period and daily during the 8-week post-intervention follow-up period
|
Frequency and severity of hot flashes and night sweats will be recorded using a daily symptom diary.
|
Daily throughout the 12-week intervention period and daily during the 8-week post-intervention follow-up period
|
合作者和调查者
出版物和有用的链接
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.